Dhaka turned to India for vaccine after China wanted Bangladesh to share clinical trials' cost
Amidst questions over the efficacy of Chinese CoronaVac vaccine, Bangladesh turned towards India for the supply of Serum Institute of India (SII)’s Covishield jab after Beijing brazenly asked Dhaka to share costs of clinical trials of Sinovac manufactured drug in the SAARC country.
India, in sharp contrast, sent a gift of two million doses of Covishield vaccine to Dhaka on January 21 as well as facilitated a commercial contract of 30 million doses with the Pune-based SII. The Indian gift to Dhaka was a fulfilment of the assurance given by Prime Minister Narendra Modi to Bangladesh's Prime Minister Sheikh Hasina during the December 17, 2020, virtual summit. Both the countries have been cooperating in the field of Covid-19 vaccine, including Phase III testing, distribution, co-production and delivery in Bangladesh.
The leadership of Sri Lanka and Nepal also expressed their apprehension about the Chinese vaccine to their Indian interlocutors. The demand of Indian vaccine has come from small countries far and away like Barbados, whose Prime Minister Mia Amor Mottley wrote to PM Modi on January 22 for the supply of 200,000 doses of the Oxford-AstraZeneca vaccine with the proviso of purchasing half of the doses. The request has been approved.
According to diplomats based in Dhaka and Delhi, around October 2020, the Chinese wanted to sign a contract with the Sheikh Hasina government to supply CoronaVac vaccines. One of the terms of the contract was that Dhaka had to share the cost of the clinical trials. While Dhaka refused to share the cost of the trials, the Chinese company said that Bangladesh could not be an exception to not sharing costs as Sinovac was putting the same conditions for countries in which clinical trials were conducted and as a precursor to jab supplies.
Also read | Global Covid-19 infections near 100 million mark
It was only then that Dhaka moved swiftly and tied up with SII with the Modi government doing the facilitation for commercial supply of 30 million doses of the Oxford-AstraZeneca vaccine. Three million doses of commercial supplies have already landed in Dhaka.
India has already rolled out five million doses of the coronavirus vaccine to seven countries in the neighbourhood, the first being Bhutan on January 20 and the latest being Mauritius on January 22.
Enter your email to get our daily newsletter in your inbox
- The meeting came a week after Tewari and other letter writers, the group has been tagged the G23, addressed a meeting in Jammu in honour of retired MP Ghulam Nabi Azad.
- In Tamil Nadu, the Congress is in alliance with the Dravida Munnetra Kazhagham (DMK).
- The observations from the Union health ministry come a day after the country reported the largest single-day increase in new Covid-19 infections in two months.
- Smriti Irani says, "I’m the only female politician who’s also recognised by her former vocation. I recognise the bias in that."
- An official said that both Houses could meet at 11 am from the second week following the vaccination of eligible MPs.
- A suicide note found at the spot said they took the decision because of acute financial distress, an official said.
- The changes have been opposed by some states who see it as another attempt by the Centre to take over mining auctions and impose central rules on a state domain.
- A re-invigorated biodiversity management policy is India’s survival strategy. At this point in our development trajectory, we don’t pay any heed to either biodiversity or landscape conservation.
- According to Forest Survey of India’s forest fire alert system, there were 2,317 fire points last year between February 26 and March 7, but the figure rose to 53,211 this time after data from the Suomi National Polar-orbiting Partnership (SNPP) was taken into account.